HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[A study of an immunosuppressive acidic protein (IAP) in patients with a bone tumor].

Abstract
We evaluated an immunosuppressive acidic protein (IAP) as a tumor marker in cases of a tumor of the bone (benign, 21; primary malignant, 26; metastatic carcinoma, 12). The IAP positive rate of a primary malignant tumor of the bone was 60%, and the mean was 591 + 59.4 micrograms/ml. This rate of a benign tumor of the bone was 10%, and the mean was 382 +/- 31.3 micrograms/ml. IAP may represent a tumor marker in malignant tumors of the bone.
AuthorsO Mori, K Yonemura, K Morisawa
JournalGan no rinsho. Japan journal of cancer clinics (Gan No Rinsho) Vol. 34 Issue 12 Pg. 1690-2 (Oct 1988) ISSN: 0021-4949 [Print] Japan
PMID3193614 (Publication Type: English Abstract, Journal Article)
Chemical References
  • Biomarkers, Tumor
  • Neoplasm Proteins
  • immunosuppressive acidic protein
Topics
  • Biomarkers, Tumor (analysis)
  • Bone Neoplasms (analysis)
  • Chondroma (analysis)
  • Chondrosarcoma (analysis)
  • Humans
  • Neoplasm Proteins (analysis)
  • Osteosarcoma (analysis)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: